-transparent.png){kind=logo}
The metabolism of trimethadione (TMO), a useful indicator of hepatic drug-oxidizing capacity in rats and humans, was studied using 14 different forms of rat cytochrome P450 (CYP1A1, 1A2, 2A1, 2A2, 2B1, 2B2, 2C6, 2C7, 2C11, 2C12, 2C13, 2E1, 3A2 and 4A2) and three forms of human cytochrome P450 (CYP1A2, 2C and 3A4). TMO N-demethylation was increased by treating rats with phenobarbital. CYP2C11 and 2B1 had high TMO N-demethylase activity, but 1A1 and 1A2 had low activity. Antibodies raised to CYP2C11 and 2B1/2 inhibited TMO N-demethylation in hepatic microsomes of untreated and phenobarbital-treated rats, respectively. In a reconstituted system, human CYP3A4 and 2C produced efficiently dimethadione (DMO), but CYP1A2 did not catalyse TMO N-demethylation. Antibodies raised to CYP3A2 and 2C11 inhibited TMO N-demethylation in human hepatic microsomes. These results indicated that the N-demethylation of TMO is catalysed mainly by CYP2C11 and 2B1 in rat hepatic microsomes, and that human CYP3A4 and an unspecified isoform of the 2C subfamilies contribute to TMO N-demethylation in human liver.
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
January 1996,
Methods in enzymology,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
February 1993,
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
September 1985,
Journal of pharmacobio-dynamics,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
November 1996,
Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
January 1992,
Drug metabolism and disposition: the biological fate of chemicals,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
June 1990,
Research communications in chemical pathology and pharmacology,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
August 1995,
Journal of gastroenterology,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
July 1983,
Journal of pharmacobio-dynamics,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
May 1986,
Journal of pharmacobio-dynamics,
M Nakamura, and
E Tanaka, and
S Misawa, and
T Shimada, and
S Imaoka, and
Y Funae
March 1987,
British journal of clinical pharmacology,
